ANKRD28 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.802200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.752200E-01
Normal-vs-Stage2
7.332600E-01
Normal-vs-Stage3
1.321840E-01
Normal-vs-Stage4
4.298000E-01
Stage1-vs-Stage2
5.097000E-01
Stage1-vs-Stage3
2.961000E-01
Stage1-vs-Stage4
6.844000E-02
Stage2-vs-Stage3
1.484150E-01
Stage2-vs-Stage4
1.413790E-01
Stage3-vs-Stage4
7.032500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.953800E-01
Normal-vs-AfricanAmerican
7.022800E-01
Normal-vs-Asian
3.703400E-01
Caucasian-vs-AfricanAmerican
9.905600E-01
Caucasian-vs-Asian
3.737400E-01
AfricanAmerican-vs-Asian
5.691600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.632800E-01
Normal-vs-Female
8.448000E-01
Male-vs-Female
1.400160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.780400E-01
Normal-vs-Age(41-60Yrs)
9.343000E-01
Normal-vs-Age(61-80Yrs)
5.265000E-01
Normal-vs-Age(81-100Yrs)
3.808400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.945200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.611200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.889800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.421840E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.564200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.248000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.276400E-01
Normal-vs-Daily Drinker
3.274800E-01
Normal-vs-Weekly Drinker
9.427000E-01
Normal-vs-Occasional Drinker
9.612400E-01
Normal-vs-Social Drinker
8.717800E-01
Non Drinker-vs-Daily Drinker
8.188000E-01
Non Drinker-vs-Weekly Drinker
2.400200E-01
Non Drinker-vs-Occasional Drinker
1.911240E-01
Non Drinker-vs-Social Drinker
2.725400E-01
Daily Drinker-vs-Weekly Drinker
1.859170E-01
Daily Drinker-vs-Occasional Drinker
1.493610E-01
Daily Drinker-vs-Social Drinker
2.035800E-01
Weekly Drinker-vs-Occasional Drinker
9.684000E-01
Weekly Drinker-vs-Social Drinker
9.026800E-01
Occasional Drinker-vs-Social Drinker
8.640200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.035800E-01
Normal-vs-Grade 2
9.781600E-01
Normal-vs-Grade 3
9.095000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.391500E-02
Grade 1-vs-Grade 3
5.415500E-03
Grade 1-vs-Grade 4
9.035800E-01
Grade 2-vs-Grade 3
1.455380E-01
Grade 2-vs-Grade 4
9.781600E-01
Grade 3-vs-Grade 4
9.095000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.245200E-01
Normal-vs-NonDiabetic
6.039800E-01
Diabetic-vs-NonDiabetic
9.228400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.567000E-01
Normal-vs-NoPancreatitis
6.186200E-01
Pancreatitis-vs-NoPancreatitis
9.876000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.507400E-01
Normal-vs-N1
7.632400E-01
N0-vs-N1
3.702600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.494800E-01
Normal-vs-TP53-NonMutant
8.628400E-02
TP53-Mutant-vs-TP53-NonMutant
1.206210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
